News from vividion therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 19, 2020, 03:05 ET Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases

Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally...


May 15, 2020, 08:00 ET Vividion Therapeutics to Present Data on Novel Covalent E3 Ligase Engager Supporting Broad Targeted Protein Degradation at 2020 AACR Annual Meeting

Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally...


Feb 11, 2020, 08:00 ET Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer

Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally...


Apr 30, 2019, 06:00 ET Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing

Vividion Therapeutics, a biotechnology company with a revolutionary platform to discover small molecule therapeutics against biologically compelling...


Sep 25, 2018, 08:11 ET Vividion Therapeutics Expands Leadership Team with the Appointments of Fred Aslan, M.D., President and Chief Business Officer, and Larry Burgess, Ph.D., Head of Chemistry

Vividion Therapeutics, a biotechnology company applying revolutionary proteomics and chemistry platforms to discover and develop novel small molecule ...


Mar 05, 2018, 05:00 ET Vividion Therapeutics Announces Strategic Research Collaboration with Celgene Corporation to Discover Therapies Against Transformative, First-in-Class Targets

Vividion Therapeutics, Inc., a biotechnology company using revolutionary proteomics and chemistry platforms, today announced a strategic research...


Sep 07, 2017, 08:00 ET Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer

Vividion Therapeutics, a newly established biotechnology company using revolutionary proteomics and chemistry platforms to discover and develop novel ...